Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Has Made The -14.41% Recovery, Could Gain Another -3276.27% Ahead
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.49 million shares changing hands at last check today with its beta currently measuring 0.25. Company’s